Experts at HLTH Europe 2026 agreed that healthcare innovations won't meet their full potential until healthcare services can implement them.

The initiative is designed to simplify the ability for GE HealthCare customers with existing interventional suites to access new technologies.

Artivion has received the PMA clearance from the US FDA for AMDS Hybrid Prosthesis device, permitting its use in treating acute DeBakey Type I aortic dissections with clinical or radiographic ...

Roche has introduced its Axelios 1 platform, a next-generation sequencing system that is available for research use and powered by its SBX technology.

HB Fuller says the AMS acquisition would expand its TAM by $15bn, while bringing in around $300m in extra annual revenue.

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

Quest Diagnostics has received approval from the NYSDOH CLEP for its Haystack MRD test, expanding its use to cancer patients throughout the US.

Tissium will now bring COAPTIUM CONNECT, the first atraumatic peripheral nerve repair surgical system, to patients in the US.

FiberSense’s device uses optical sensor technology to monitor the concentration of glucose in the subcutaneous tissue fluid.

Experts at HLTH Europe 2026 note that patient adherence-focused health technologies should be flexible, engaging, adaptable and affordable.

Researchers from the UF Health Cancer Institute in the US are developing a rapid, non-invasive urine test aimed at diagnosing prostate cancer and distinguishing it from other prostate-related ...

CereVasc has concluded patient enrolment in its STRIDE study, assessing the safety and effectiveness of the eShunt system for NPH.